Roche Diagnostics ALBT2, Tina-quant Albumin Gen. 2, COBAS… recallZ-0011-2009 · Roche Diagnostics Corp. · initiated Jun 11, 2008
Terminated All recalls posted in October 2008
Is my device affected?
- Compare the model, catalog and lot or serial numbers on your device or its packaging with the code information below. A recall usually covers only specific models or lots.
- If yours is listed, follow the instructions from Roche Diagnostics Corp. or your healthcare provider. The company's action is summarized under what the company is doing.
- Do not stop using a prescribed or implanted device on your own — talk to your healthcare provider first.
Where to find your model and lot numbers · What recall classes and statuses mean
Why it was recalled
Some of the labels are glossy, resulting in the bar code being difficult to read by the bar code reader.
FDA root cause category: Labeling Change Control
What the company is doing
Consignees were notified via an Urgent Medical Device correction letter dated 6/11/08 informing users of the problem and providing them with work-around instructions. The instructions suggests 1) inserting the cassette rack slowly; 2) using mainly reagent slots A, B, or C; 3) tilting the rack slightly clockwise so the barcode scanner does not read the barcode at an exact 90 degree angle; and 4) confirming the rack is properly seated on the track and displayed on the Cassette Status screen. If the cassette barcode does not register after following the Work-Around instructions, then customers are required to contact Diagnostics Technical Support.
Recall details
- Recall number
- Z-0011-2009
- Recall class
- Not yet classified by the FDA
- Status
- Terminated
- Initiated by the company
- Jun 11, 2008
- Posted by the FDA
- Oct 9, 2008
- Recalling firm
- Roche Diagnostics Corp.
- Quantity
- 124
- Product code
- CIX
- FDA submissions
- K033009
- Distribution
- Nationwide Distribution
Product description
Roche Diagnostics ALBT2, Tina-quant Albumin Gen. 2, COBAS INTEGRA, cobas c systems, Roche Diagnostics, Indianapolis, IN.; 04469658190. An in-vitro diagnostic reagent system intended for use on COBAS Integra systems for the quantitative determination of albumin concentration in serum and plasma.
Code information (models, lots, serial numbers)
Lot 60087801.
Other devices under the same FDA submission
4 devices cleared under K033009 — the recall does not name any of them by identifier. One submission often covers many models, so they may or may not be affected.
- Albumin Gen2 5166861190Roche Diagnostics GmbH · BROMCRESOL GREEN DYE-BINDING, ALBUMIN8 reports
- Albumin Gen.2 08056692190Roche Diagnostics GmbH · BROMCRESOL GREEN DYE-BINDING, ALBUMIN6 reports
- Albumin Gen2 3183688122Roche Diagnostics GmbH · BROMCRESOL GREEN DYE-BINDING, ALBUMIN5 reports
- Albumin Gen.2 08056714190Roche Diagnostics GmbH · BROMCRESOL GREEN DYE-BINDING, ALBUMIN5 reports
Other products in the same recall event
The FDA groups related products into one recall event (event 48638).
- Z-0007-2009 · TerminatedRoche Diagnostics IRON2, Iron Gen. 2, COBAS INTEGRA, cobas c systems, Roche Diagnostics, Indianapolis, IN.; 03183696122. An in-vitro diagnostic reagent system intended for use on …
- Z-0008-2009 · TerminatedRoche Diagnostics CREP2, Creatinine Plus Ver. 2, COBAS INTEGRA, cobas c systems, Roche Diagnostics, Indianapolis, IN.; 03263991190. An in-vitro diagnostic reagent system intended …
- Z-0012-2009 · TerminatedRoche Diagnostics NAPA2, N-Acetyl-Procainamide, COBAS INTEGRA, Roche Diagnostics, Indianapolis, IN.; 20737852322. An in-vitro diagnostic reagent system intended for use on COBAS I…
Sources and updates
- Recall record: FDA Medical Device Recalls, file dated Oct 16, 2026 · View the FDA recall notice ↗
- Devices: FDA GUDID, file dated Oct 13, 2026. Devices are linked when their identifier (with a valid check digit) appears in the recall's code information.
- Page last rebuilt: Oct 18, 2026. Text above is shown as published by the FDA.
How recalls are matched to devices · Editorial policy · Report an error on this page